Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy.
about
Does zafirlukast reduce future risk of asthma exacerbations in adults? Systematic review and meta-analysisIs there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies?Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitisAntileukotrienes in upper airway inflammatory diseasesLeukotriene B4 levels in sputum from asthma patientsImmunoglobulin E-mediated airway inflammation is active in most patients with asthma.Influence of leukotriene pathway polymorphisms on response to montelukast in asthma.Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury.Role of Leukotrienes and Leukotriene Modifiers in Asthma.Characterization of leukotrienes in a pilot study of older asthma subjectsEffects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammationUrinary LTE4 levels as a diagnostic marker for IgE-mediated asthma in preschool children: a birth cohort study.Allergy and asthma in the elderly.Leukotrienes and airway inflammationPharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues.Urinary leukotriene E₄ levels identify children with tobacco smoke exposure at risk for asthma exacerbation.Sensitization to food and inhalant allergens in relation to atopic diseases in early childhood: a birth cohort study.Ozone enhancement of lower airway allergic inflammation is prevented by gamma-tocopherol.Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2.Changes in immune function in asthma in the elderlySystemic leukotriene B4 receptor antagonism lowers arterial blood pressure and improves autonomic function in the spontaneously hypertensive rat.Efficacy of add-on montelukast in nonasthmatic eosinophilic bronchitis: the additive effect on airway inflammation, cough and life quality.Immunoglobulin E blockade in the treatment of asthma.Leukocyte lipid bodies - Biogenesis and functions in inflammationRole of leukotriene receptor antagonists in the management of pediatric asthma: an update.Role of leukotriene antagonists and antihistamines in the treatment of allergic rhinitis.Synthesis of tenascin and laminin beta2 chain in human bronchial epithelial cells is enhanced by cysteinyl leukotrienes via CysLT1 receptor.Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549).Eosinophilic inflammation in allergic asthma.Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines.Gamma-tocopherol prevents airway eosinophilia and mucous cell hyperplasia in experimentally induced allergic rhinitis and asthma.Managing asthma in the community: a guide for nursing staff.Recognising and managing allergic disease in the community.Particulate levels are associated with early asthma worsening in children with persistent disease.
P2860
Q26863510-FEFFEDE6-FDCB-4583-96C5-5AD90FED768BQ26998459-AA139E9F-C8B1-47F5-9A08-F4BFA4E77EECQ28219122-C881D009-563F-49D2-8D22-6D54F1B9B4CAQ28267571-4251F6A9-19F8-4B54-ADFC-23FE57C9FB0CQ28587885-D77EC104-F9FD-4CEE-9582-4BDA261CF9E0Q30444397-24C9FF03-6036-44CC-985E-A7C519578D3FQ33227414-5CBC36FB-7C5A-43BE-9F22-9DC2E981A449Q33657698-9897D0DA-DCA0-4048-B9C7-3AFEF823D545Q33664150-47CD34A0-75FE-45FC-BD63-5CF89AFB1F59Q34008461-9576C7AC-A9A8-4F41-896C-907AF2F2F7BAQ34124817-52ECC425-289C-48BD-946F-E95C10CCFF94Q34734095-0F564162-D9BA-489A-A864-A2DBE8CD5784Q34779858-9FD4C2FB-4402-48BB-BFDD-76551EEDAA86Q35106124-79421641-88DA-4FC9-9534-810369F99E63Q35113606-5FF3FC29-895C-44BE-AD1C-8D3066CC0699Q35147947-BC9EBEA0-0D67-4141-BABC-E398BE01D176Q35208369-A5C9B6F8-80F5-4C06-9548-3B33D1B21E47Q35737817-FFBD3818-BEAD-4B99-9064-E28BE70B0327Q35738005-E8FA0489-1100-41A8-A86A-8A3B89328D95Q35986169-1BC24ED7-7EB8-448F-8494-601BE5F7E240Q36031902-F82B9EBD-F477-421B-931C-ED78C53F111AQ36816193-F58D7559-9078-4143-89DF-59F58D0DF165Q36951998-864772DC-DD12-4974-B8CC-5ABA21A39997Q37471003-467549D7-6208-4904-A80C-996EE6493F3DQ38034994-DDECC41F-72D1-4F37-929C-8A23B91CA8C5Q38079750-5C9D7A81-F12E-4587-9E4E-73DE8E5C51A0Q38843448-D1519DBD-2B26-437E-81AF-7E92E8F08F48Q39639718-A2D44E93-02A7-4701-A564-335064A07C16Q39885996-8FA35695-B229-4065-B73D-FDC68ADD3D6EQ42118581-6142C02A-6FD0-4B4D-B0B3-2EA6975BFBC3Q46923549-F115CFA9-D570-497F-88CA-5B7CD4EA506FQ50234884-4A178577-26AE-4A3F-91D5-BB272D390B15Q50243060-DDC6E62B-732B-47D8-8BB5-A06B4AED0ABFQ54177364-F11E6B21-6010-4B4E-A525-69ACB0E75B74
P2860
Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy.
@ast
Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy.
@en
type
label
Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy.
@ast
Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy.
@en
prefLabel
Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy.
@ast
Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy.
@en
P356
P1433
P1476
Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy.
@en
P2093
Monica Kraft
P304
P356
10.1378/CHEST.127.4.1312
P407
P577
2005-04-01T00:00:00Z